Investing.com - Surface Oncology (NASDAQ: SURF) reported second quarter EPS of $-0.460, $0.13 worse than the analyst estimate of $-0.332. Revenue for the quarter came in at $0.00 versus the consensus estimate of $0.00.
Surface Oncology's stock price closed at $0.940. It is up 57.720% in the last 3 months and down -47.410% in the last 12 months.
Surface Oncology saw 0 positive EPS revisions and 0 negative EPS revisions in the last 90 days. See Surface Oncology's stock price’s past reactions to earnings here.
According to InvestingPro, Surface Oncology's Financial Health score is "fair performance".
Check out Surface Oncology's recent earnings performance, and Surface Oncology's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar